Michael C. Donegan - Apr 12, 2023 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role
Prin. Fin. and Acctg. Officer
Signature
/s/ Michael C. Donegan
Stock symbol
TXMD
Transactions as of
Apr 12, 2023
Transactions value $
$0
Form type
4
Date filed
4/14/2023, 07:17 PM
Previous filing
Feb 23, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXMD Common Stock Options Exercise $0 +50K +421.83% $0.00 61.9K Apr 12, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXMD Restricted Stock Units Options Exercise $0 -50K -100% $0.00* 0 Apr 12, 2023 Common Stock 50K $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of issuer common stock upon settlement. On April 12, 2023, the reporting person received 50,000 shares of issuer common stock in settlement of restricted stock units (RSUs).
F2 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs vested in full on March 31, 2023.